180 related articles for article (PubMed ID: 32657887)
1. MRI of neurodegeneration with brain iron accumulation.
Lehéricy S; Roze E; Goizet C; Mochel F
Curr Opin Neurol; 2020 Aug; 33(4):462-473. PubMed ID: 32657887
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.
van Bergen JM; Hua J; Unschuld PG; Lim IA; Jones CK; Margolis RL; Ross CA; van Zijl PC; Li X
AJNR Am J Neuroradiol; 2016 May; 37(5):789-96. PubMed ID: 26680466
[TBL] [Abstract][Full Text] [Related]
3. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.
McNeill A; Birchall D; Hayflick SJ; Gregory A; Schenk JF; Zimmerman EA; Shang H; Miyajima H; Chinnery PF
Neurology; 2008 Apr; 70(18):1614-9. PubMed ID: 18443312
[TBL] [Abstract][Full Text] [Related]
4. Cortical pencil lining on SWI MRI in NBIA and healthy aging.
van der Weijden MCM; van Laar PJ; Lambrechts RA; Verbeek DS; Tijssen MAJ
BMC Neurol; 2019 Oct; 19(1):233. PubMed ID: 31607263
[TBL] [Abstract][Full Text] [Related]
5. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
Yarnykh VL; Krutenkova EP; Aitmagambetova G; Repovic P; Mayadev A; Qian P; Jung Henson LK; Gangadharan B; Bowen JD
AJNR Am J Neuroradiol; 2018 Apr; 39(4):618-625. PubMed ID: 29439122
[TBL] [Abstract][Full Text] [Related]
6. Deep Gray Matter Iron Deposition and Its Relationship to Clinical Features in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients: A 7.0-T Magnetic Resonance Imaging Study.
Sun C; Wu Y; Ling C; Xie Z; Kong Q; Fang X; An J; Sun Y; Zhang W; Yang Q; Wang Z; Zhang Z; Yuan Y
Stroke; 2020 Jun; 51(6):1750-1757. PubMed ID: 32397933
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
8. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
[TBL] [Abstract][Full Text] [Related]
9. Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
Dusek P; Mekle R; Skowronska M; Acosta-Cabronero J; Huelnhagen T; Robinson SD; Schubert F; Deschauer M; Els A; Ittermann B; Schottmann G; Madai VI; Paul F; Klopstock T; Kmiec T; Niendorf T; Wuerfel J; Schneider SA
Mov Disord; 2020 Jan; 35(1):142-150. PubMed ID: 31518459
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mutation in Neurodegeneration with Brain Iron Accumulation - A Case Report.
Nagarjunakonda S; Daggumati R; Uppala V; Gajula R; Amalakanti S
Neurol India; 2019; 67(5):1341-1343. PubMed ID: 31744972
[TBL] [Abstract][Full Text] [Related]
11. Quantitative susceptibility mapping shows lower brain iron content in children with autism.
Tang S; Xu Y; Liu X; Chen Z; Zhou Y; Nie L; He L
Eur Radiol; 2021 Apr; 31(4):2073-2083. PubMed ID: 32945969
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging features of neurodegeneration with brain iron accumulation.
Kruer MC; Boddaert N; Schneider SA; Houlden H; Bhatia KP; Gregory A; Anderson JC; Rooney WD; Hogarth P; Hayflick SJ
AJNR Am J Neuroradiol; 2012 Mar; 33(3):407-14. PubMed ID: 21920862
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological variability in neurodegeneration with brain iron accumulation.
Vincze A; Kapás I; Molnar MJ; Kovács GG
Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671
[TBL] [Abstract][Full Text] [Related]
14. Substantia Nigra Swelling and Dentate Nucleus T2 Hyperintensity May Be Early Magnetic Resonance Imaging Signs of β-Propeller Protein-Associated Neurodegeneration.
Russo C; Ardissone A; Freri E; Gasperini S; Moscatelli M; Zorzi G; Panteghini C; Castellotti B; Garavaglia B; Nardocci N; Chiapparini L
Mov Disord Clin Pract; 2019 Jan; 6(1):51-56. PubMed ID: 30746416
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
Neumann M; Adler S; Schlüter O; Kremmer E; Benecke R; Kretzschmar HA
Acta Neuropathol; 2000 Nov; 100(5):568-74. PubMed ID: 11045680
[TBL] [Abstract][Full Text] [Related]
16. Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.
Abusrair AH; Bohlega S; Al-Semari A; Al-Ajlan FS; Al-Ahmadi K; Mohamed B; AlDakheel A
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2256-2262. PubMed ID: 30409855
[TBL] [Abstract][Full Text] [Related]
17. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation?
Skowrońska M; Litwin T; Dzieżyc K; Wierzchowska A; Członkowska A
Neurol Neurochir Pol; 2013; 47(6):542-6. PubMed ID: 24374999
[TBL] [Abstract][Full Text] [Related]
18. Deep grey matter iron accumulation in alcohol use disorder.
Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
[TBL] [Abstract][Full Text] [Related]
19. CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS.
Burgetova A; Dusek P; Uher T; Vaneckova M; Vejrazka M; Burgetova R; Horakova D; Srpova B; Kalousova M; Noskova L; Levova K; Krasensky J; Lambert L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373196
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Imaging Presentation of a Patient with Beta-Propeller Protein-Associated Neurodegeneration, a Rare and Sporadic form of Neurodegeneration with Brain Iron Accumulation (NBIA).
Hattingen E; Handke N; Cremer K; Hoffjan S; Kukuk GM
Clin Neuroradiol; 2017 Dec; 27(4):481-483. PubMed ID: 28643035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
